Baseline pain medication is associated with longer duration of high adherence in a three-month digital treatment program for hip and knee osteoarthritis
(2026) In Osteoarthritis and Cartilage Open 8(1).- Abstract
Objective: To investigate whether baseline use of pain medication is associated with program adherence during a three-month digital treatment program for individuals with hip or knee osteoarthritis (OA). Design: An observational cohort study using registry data on weekly participant adherence from 33078 participants enrolled in a digital education and exercise therapy program. Poor adherence was defined as completing less than 80 % of the approximately 20 prescribed weekly activities for two consecutive weeks during the 13-week treatment period. Baseline analgesic use was categorized into six groups: no medication, paracetamol (with/without dietary supplements), NSAIDs (with/without supplements), paracetamol combined with NSAIDs... (More)
Objective: To investigate whether baseline use of pain medication is associated with program adherence during a three-month digital treatment program for individuals with hip or knee osteoarthritis (OA). Design: An observational cohort study using registry data on weekly participant adherence from 33078 participants enrolled in a digital education and exercise therapy program. Poor adherence was defined as completing less than 80 % of the approximately 20 prescribed weekly activities for two consecutive weeks during the 13-week treatment period. Baseline analgesic use was categorized into six groups: no medication, paracetamol (with/without dietary supplements), NSAIDs (with/without supplements), paracetamol combined with NSAIDs (with/without dietary supplements), dietary supplements only, and opioids (with/without other medications). Interval-censored parametric survival models adjusted for baseline characteristics were used for statistical analysis. In sensitivity analyses, alternative definitions of poor adherence were used. A complete case analysis was conducted as a subgroup analysis. Results: Compared to the no-medication group, individuals taking paracetamol—either alone (hazard ratio 0.94, 95 % CI 0.91, 0.98) or in combination with NSAIDs (0.91, 0.87, 0.94) reached poor adherence later. In contrast, opioid users (hazard ratio 1.12, 95 % CI 1.06, 1.19) reached poor adherence earlier. Adjusted median days to reach poor adherence ranged from 39.2 (95 % CI 36.9, 41.4) for opioids to 49.2 (47.7, 50.7) for paracetamol + NSAIDs users. Alternative definitions of poor adherence and a complete-case analysis generally yielded similar findings. Conclusion: Baseline use of paracetamol, alone or with NSAIDs, was associated with longer time to reach poor adherence, whereas opioid use predicted poor adherence earlier.
(Less)
- author
- Dahlberg, Leif E.
LU
; Rowland, Simon P.
; Pearson, Jack T.
; Lohmander, L. Stefan
LU
and Kiadaliri, Ali
LU
- organization
-
- Lund OsteoArthritis Division - From molecule to clinical implementation (research group)
- Lund OsteoArthritis Division - Molecular marker research group (research group)
- EpiHealth: Epidemiology for Health
- Lund OsteoArthritis Division - Clinical Epidemiology Unit (research group)
- LU Profile Area: Proactive Ageing
- publishing date
- 2026-03
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- eHealth, Osteoarthritis, Pain medication, Physiotherapy
- in
- Osteoarthritis and Cartilage Open
- volume
- 8
- issue
- 1
- article number
- 100727
- publisher
- Elsevier
- external identifiers
-
- pmid:41536420
- scopus:105025044305
- ISSN
- 2665-9131
- DOI
- 10.1016/j.ocarto.2025.100727
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2025 The Authors
- id
- ccbf27f0-b1a2-43eb-b1db-f2c25edd7d45
- date added to LUP
- 2026-03-09 11:16:49
- date last changed
- 2026-03-10 03:00:07
@article{ccbf27f0-b1a2-43eb-b1db-f2c25edd7d45,
abstract = {{<p>Objective: To investigate whether baseline use of pain medication is associated with program adherence during a three-month digital treatment program for individuals with hip or knee osteoarthritis (OA). Design: An observational cohort study using registry data on weekly participant adherence from 33078 participants enrolled in a digital education and exercise therapy program. Poor adherence was defined as completing less than 80 % of the approximately 20 prescribed weekly activities for two consecutive weeks during the 13-week treatment period. Baseline analgesic use was categorized into six groups: no medication, paracetamol (with/without dietary supplements), NSAIDs (with/without supplements), paracetamol combined with NSAIDs (with/without dietary supplements), dietary supplements only, and opioids (with/without other medications). Interval-censored parametric survival models adjusted for baseline characteristics were used for statistical analysis. In sensitivity analyses, alternative definitions of poor adherence were used. A complete case analysis was conducted as a subgroup analysis. Results: Compared to the no-medication group, individuals taking paracetamol—either alone (hazard ratio 0.94, 95 % CI 0.91, 0.98) or in combination with NSAIDs (0.91, 0.87, 0.94) reached poor adherence later. In contrast, opioid users (hazard ratio 1.12, 95 % CI 1.06, 1.19) reached poor adherence earlier. Adjusted median days to reach poor adherence ranged from 39.2 (95 % CI 36.9, 41.4) for opioids to 49.2 (47.7, 50.7) for paracetamol + NSAIDs users. Alternative definitions of poor adherence and a complete-case analysis generally yielded similar findings. Conclusion: Baseline use of paracetamol, alone or with NSAIDs, was associated with longer time to reach poor adherence, whereas opioid use predicted poor adherence earlier.</p>}},
author = {{Dahlberg, Leif E. and Rowland, Simon P. and Pearson, Jack T. and Lohmander, L. Stefan and Kiadaliri, Ali}},
issn = {{2665-9131}},
keywords = {{eHealth; Osteoarthritis; Pain medication; Physiotherapy}},
language = {{eng}},
number = {{1}},
publisher = {{Elsevier}},
series = {{Osteoarthritis and Cartilage Open}},
title = {{Baseline pain medication is associated with longer duration of high adherence in a three-month digital treatment program for hip and knee osteoarthritis}},
url = {{http://dx.doi.org/10.1016/j.ocarto.2025.100727}},
doi = {{10.1016/j.ocarto.2025.100727}},
volume = {{8}},
year = {{2026}},
}